Literature DB >> 20704559

Patterns of cognitive decline and rates of conversion to dementia in patients with degenerative and vascular forms of MCI.

Camillo Marra1, Monica Ferraccioli, Maria Gabriella Vita, Davide Quaranta, Guido Gainotti.   

Abstract

According to recent criteria, Mild Cognitive Impairment (MCI) represents a clinical condition with multiple cognitive presentations (amnesic and non amnesic) that can be supported by different types of brain lesions (mainly vascular and atrophic). In order to asses if the cognitive presentation and the rate of progression differ according to the type of brain pathology, two populations of MCI patients, characterized by hippocampal atrophy (n: 39) and vascular subcortical pathology (n: 36) respectively, on the basis of MRI findings, were investigated. Patients underwent an extensive neuropsychological test battery twice (at baseline and at two years follow-up), which is made up of the MMSE and various tests of episodic memory, short-term memory, visual-spatial abilities, executive functions, language, attention, praxis and psychomotor speed. Atrophic and vascular MCI patients showed a remarkably different pattern of impairment at the baseline. The former were significantly more impaired in episodic memory tasks. The latter were more impaired in an action naming task. At the follow up examination, the rate of progression to dementia was higher in atrophic (14/39) than in vascular (5/36) MCI patients. The comparison between neuropsychological scores obtained at the baseline and at the follow-up showed that atrophic MCI patients underwent a severe decline in several cognitive domains, whereas vascular MCI patients showed a significant decline only in those tasks requiring executive abilities. Our results confirm that a selective and severe defect of episodic memory is associated with hippocampal atrophy and that MCI patients with atrophic lesions are more likely to convert to Alzheimer's type dementia while MCI patients with vascular lesions are characterized by a slight decline in executive function over time and by a tendency to develop probable vascular forms of dementia.

Entities:  

Mesh:

Year:  2011        PMID: 20704559     DOI: 10.2174/156720511794604552

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  15 in total

1.  A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment.

Authors:  Laura E Gibbons; Adam C Carle; R Scott Mackin; Danielle Harvey; Shubhabrata Mukherjee; Philip Insel; S McKay Curtis; Dan Mungas; Paul K Crane
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

Review 2.  Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings.

Authors:  Meredith N Braskie; Paul M Thompson
Journal:  Trends Cogn Sci       Date:  2013-09-09       Impact factor: 20.229

3.  Weaker circadian activity rhythms are associated with poorer executive function in older women.

Authors:  Christine M Walsh; Terri Blackwell; Gregory J Tranah; Katie L Stone; Sonia Ancoli-Israel; Susan Redline; Misti Paudel; Joel H Kramer; Kristine Yaffe
Journal:  Sleep       Date:  2014-12-01       Impact factor: 5.849

Review 4.  The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease.

Authors:  Chelsea C Hays; Zvinka Z Zlatar; Christina E Wierenga
Journal:  Cell Mol Neurobiol       Date:  2016-02-22       Impact factor: 5.046

Review 5.  Effects of disease modifying treatments on cognitive dysfunction in multiple sclerosis.

Authors:  Giancarlo Comi
Journal:  Neurol Sci       Date:  2010-11       Impact factor: 3.307

6.  Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition.

Authors:  Christina E Wierenga; Sheena I Dev; David D Shin; Lindsay R Clark; Katherine J Bangen; Amy J Jak; Robert A Rissman; Thomas T Liu; David P Salmon; Mark W Bondi
Journal:  J Cereb Blood Flow Metab       Date:  2012-05-02       Impact factor: 6.200

7.  Walking stabilizes cognitive functioning in Alzheimer's disease (AD) across one year.

Authors:  J Winchester; M B Dick; D Gillen; B Reed; B Miller; J Tinklenberg; D Mungas; H Chui; D Galasko; L Hewett; C W Cotman
Journal:  Arch Gerontol Geriatr       Date:  2012-09-05       Impact factor: 3.250

8.  Verbal and non-verbal memory and hippocampal volumes in a memory clinic population.

Authors:  Aaron Bonner-Jackson; Shamseldeen Mahmoud; Justin Miller; Sarah J Banks
Journal:  Alzheimers Res Ther       Date:  2015-10-15       Impact factor: 6.982

9.  Neuroimaging criteria and cognitive performance in vascular mild cognitive impairment: A systematic review.

Authors:  Felipe Kenji Sudo; Gilberto Sousa Alves; Chan Tiel; Letice Ericeira-Valente; Denise Madeira Moreira; Jerson Laks; Eliasz Engelhardt
Journal:  Dement Neuropsychol       Date:  2015 Oct-Dec

10.  Cognitive function and gait speed under normal and dual-task walking among older adults with mild cognitive impairment.

Authors:  Takehiko Doi; Hiroyuki Shimada; Hyuma Makizako; Kota Tsutsumimoto; Kazuki Uemura; Yuya Anan; Takao Suzuki
Journal:  BMC Neurol       Date:  2014-04-01       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.